Abiraterone

Abiraterone Acetate

YONSA ZYTIGA

Therapeutic Indications

Abiraterone is indicated for:

Malignant neoplasm of prostate

For this indication, the medical literature mentions below treatments (click for details):

Active ingredient Abiraterone is contraindicated in the following cases:

No gender/age discrimination

Hepatic insufficiency

No gender/age discrimination

Pregnancy

Next: Precautions >